WST stock: buy or sell?
August 22nd, 2019
West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally.
Should I buy WST stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups match with West Pharmaceutical Services stock now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is West Pharmaceutical Services stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we collected 2 ratings published for WST stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-7-26||Bank of America||Underperform||Neutral|
|2019-5-1||Jefferies Financial Group||Buy||Hold|
WST stock analysis
Despite of the negative close ($145.86, -0.05%), West Pharmaceutical Services topped new all time high at $147.19.
Shares of West Pharmaceutical Services closed today at $145.86 after marking a new all time high ($147.19) even it couldn't close with gains and remained constant a tight -0.05%. Since SMA100d and SMA200d crossed up on June, WST price climbed $27.92 per share (23.67%). On June WST price bounced up over the SMA of 50 days demonstrating to be a significant support for this stock.
West Pharmaceutical Services ended this week at $145.86 after marking a new all time high ($147.19) and stepped up a tiny 0.55%. This week was the 3rd green week in a row. Early August WST boosted an outstanding 5.81% in just one week.
WST shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom late July, WST climbed unceasignly breaking out to new all time highs. Late May, SMA20w and SMA40w crossed up triggering a rise of 25.58%. Since late March when WST stock price broke up the SMA40w line, it gained $42.45 (41.05%).
WST stock price history
WST IPO was on January 2nd, 2018 at $98.05 per share1. Since then, WST stock grew a 48.80%, with a yearly average of 48.80%. If you had invested right after WST's IPO a $1,000 in WST stock in 2018, it would worth $488.00 today.
1: Adjusted price after possible price splits or reverse-splits.
WST stock historical price chart
WST stock reached all-time highs today with a price of $147.19.
WST stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not found any price prediction for West Pharmaceutical Services stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, West Pharmaceutical Services presented its financial report, close to analysts' consensus and posted a $0.73 Earnings per Share. As soon as we get its posted EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, West Pharmaceutical Services annual revenues rose a very good 7.40% to $1,717.40 million dollars from $1,599.10 marked in 2017. In line, its income margin (compared to sales) appreciated to 12.05%, that is $206.90 million.
|2013||$1,370 M||-||$112 M8.2%||-|
|2014||$1,421 M||3.75%||$127 M8.9%||13.18%|
|2015||$1,400 M||-1.52%||$96 M6.8%||-24.78%|
|2016||$1,509 M||7.81%||$144 M9.5%||50.21%|
|2017||$1,599 M||5.96%||$151 M9.4%||4.94%|
|2018||$1,717 M||7.40%||$207 M12.0%||37.29%|
Quarterly financial resultsWest Pharmaceutical Services posted $422.50 million in sales for 2018-Q4, a -2.13% decline compared to previous quarter. Reported quarter income marked $52.00 M with a profit margin of 12.31%. Profit margin remained constant a -0.48% compared to previous quarter when profit margin was 12.79%. When comparing turnover to same quarter last year, West Pharmaceutical Services sales marked a slightly good growth and inched a 1.66%. Looking back to recent quarterly results, West Pharmaceutical Services posted 2 negative quarters in a row.
|2017-Q2||$398 M||-||$39 M9.8%||-|
|2017-Q3||$399 M||0.23%||$51 M12.8%||31.44%|
|2017-Q4||$416 M||4.24%||$0 M0.0%||-100.00%|
|2018-Q1||$416 M||0.02%||$44 M10.5%||0.00%|
|2018-Q2||$448 M||7.65%||$56 M12.5%||28.67%|
|2018-Q3||$432 M||-3.53%||$55 M12.8%||-1.60%|
|2018-Q4||$423 M||-2.13%||$52 M12.3%||-5.80%|
|2019-Q1||$444 M||4.97%||$55 M12.5%||6.54%|
West Pharmaceutical Services ownershipWhen you are planning to invest in shares of a stock, it's worth to overview its ownership structure.
West Pharmaceutical Services shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.96% of all shares.
Bearish positions for WST stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to West Pharmaceutical Services:
|Market cap||$10.7 B||$538.3 M||$44.5 B||$68.8 B||$3.4 B|
|Total shares||73.5 M||162.6 M||510.2 M||269.7 M||20.6 M|
|Float shares||73.1 M||140.2 M||509.5 M||269.1 M||19.2 M|
|- Institutional holdings (%)||95.2%||42.3%||88.2%||87.5%||93.5%|
|- Insider holdings (%)||1.0%||7.3%||0.1%||0.3%||7.1%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$144.98 - $147.19|
|Average true range||$2.70|
|50d mov avg||$130.28|
|100d mov avg||$123.64|
|200d mov avg||$113.89|
West Pharmaceutical Services performanceTo measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare West Pharmaceutical Services to Antares Pharma, Baxter International, Becton, Dickinson and, ICU Medical, , Medtronic, Stryker and Teleflex: